Literature DB >> 8396341

Stimulation of basolateral Na(+)-HCO3- cotransporter by angiotensin II in rabbit renal cortex.

S Eiam-Ong1, S A Hilden, C A Johns, N E Madias.   

Abstract

Angiotensin (ANG) II is now recognized as a powerful direct controller of Na+ reabsorption in the proximal convoluted tubule, a property that predominantly reflects stimulation of the transepithelial NaHCO3 flux. Numerous studies have established that this effect of ANG II represents stimulation of the apical Na+/H+ exchanger, but a single microperfusion study has also suggested direct stimulation of the basolateral Na(+)-HCO3- cotransporter. We have carried out studies in basolateral membrane vesicles from rabbit renal cortex to examine directly whether ANG II exerts an independent effect on the Na(+)-HCO3- cotransporter. Preincubation of vesicles with ANG II (10(-11) to 10(-9) M) for 15 min enhanced the activity of the cotransporter, the greatest effect occurring at 10(-11) M (41 +/- 1.1%, P < 0.005). This stimulation reflected an increase in the maximal enzyme reaction velocity of the cotransporter but no change in the Michaelis constant for Na+. ANG II had no effect on Na(+)-dependent succinate transport. ANG I (10(-9) M) and ANG III (10(-10) M) also stimulated the Na(+)-HCO3- cotransporter, and captopril (10(-4) M) attenuated the ANG I stimulation by 68 +/- 3.5% (P < 0.01) but not that of ANG II and III. Saralasin (10(-11) to 10(-8) M) by itself behaved as an agonist, and its stimulation was additive to that by ANG II. The nonpeptide ANG II receptor antagonist, losartan potassium (10(-6) M), and the disulfide-reducing agent, dithiothreitol (10 mM), each by itself had no effect on the cotransporter but each markedly attenuated the ANG II effect (by 77 +/- 1.4%, P < 0.01 and 74 +/- 1.6%, P < 0.005, respectively) in accord with the view that the basolateral receptor belongs to subtype 1. These results identify physiological concentrations of ANG II as a potent, direct, and specific stimulator of the basolateral Na(+)-HCO3- cotransporter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396341     DOI: 10.1152/ajprenal.1993.265.2.F195

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  Understanding the Two Faces of Low-Salt Intake.

Authors:  Branko Braam; Xiaohua Huang; William A Cupples; Shereen M Hamza
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

2.  A chloride-activated Na(+)/HCO(3)(-)-coupled transport activity in corneal endothelial membranes.

Authors:  J Lane; C G Wigham; S A Hodson
Journal:  Biophys J       Date:  2000-05       Impact factor: 4.033

3.  Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKD.

Authors:  Bodo B Beck; Howard Trachtman; Michael Gitman; Ilene Miller; John A Sayer; Andrea Pannes; Anne Baasner; Friedhelm Hildebrandt; Matthias T F Wolf
Journal:  Am J Kidney Dis       Date:  2011-09-08       Impact factor: 8.860

Review 4.  Acid-Base Basics.

Authors:  Michael F Romero; Adam J Rossano
Journal:  Semin Nephrol       Date:  2019-07       Impact factor: 5.299

5.  Effect of combination of renin inhibitor and Mas-receptor agonist in DOCA-salt-induced hypertension in rats.

Authors:  Yogendra Singh; Kulwinder Singh; P L Sharma
Journal:  Mol Cell Biochem       Date:  2012-10-30       Impact factor: 3.396

Review 6.  Losartan chemistry and its effects via AT1 mechanisms in the kidney.

Authors:  Feichao Xu; Caiping Mao; Yujuan Liu; Lei Wu; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

7.  The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.

Authors:  Jung Nam An; Jin Ho Hwang; Jung Pyo Lee; Ho Jun Chin; Sejoong Kim; Dong Ki Kim; Suhnggwon Kim; Jung Hwan Park; Sung Joon Shin; Sang Ho Lee; Bum Soon Choi; Chun Soo Lim
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

Review 8.  Regulators of Slc4 bicarbonate transporter activity.

Authors:  Ian M Thornell; Mark O Bevensee
Journal:  Front Physiol       Date:  2015-06-12       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.